In-silico based discovery of potential Keap1 inhibitors using the strategies of pharmacophore screening, molecular docking, and MD simulation studies
Open Access
- 14 September 2024
- journal article
- research article
- Published by Maad Rayan Publishing Company in BioImpacts
- Vol. 15 (1) , 30335
Abstract
Introduction: The main objective of this research is to identify potential leads for developing potent Keap1 inhibitors. Methods: In the current research article, in-silico methods have been employed to discover potential Keap1 inhibitors. 3D-QSAR was generated using the ChemBL database of Keap1 inhibitors with IC50. The best pharmacophore was selected for the screening of three different libraries namely Asinex, MiniMaybridge, and Zinc. The molecules screened from the databases were filtered through druggability rules and molecular docking studies. The best binding molecules obtained after docking studies were subjected to physicochemical properties toxicity determination by in-silico methods. The best hits were studied for stability in the cavity of Keap1 by molecular dynamic simulations. Results: The virtual screening of different databases was carried out separately and three leads, were obtained. These lead molecules ASINEX 508, MiniMaybridgeHTS_01719, and ZINC 0000952883 showed the best binding in the Keap1 cavity. The molecular dynamic simulations of the binding complexes of the leads support the docking analysis. The leads (ASINEX 508, MiniMaybridgeHTS_01719, and ZINC 0000952883) were stabilized in the Keap1 binding cavity throughout 100 ns simulation, with average RMSD values of 0.100, 0.114, and 0.106 nm, respectively. Conclusion: This research proposes three lead molecules as potential Keap1 inhibitors based on high throughput screening, docking, and MD simulation studies. These hit molecules can be used for further design and development of Keap1 inhibitors. This research provides the preliminary data for discovering novel Keap1 inhibitors. It opens new avenues for medicinal chemists to explore antioxidant-stimulating molecules targeting the Keap1-Nrf2 pathway.Keywords
This publication has 49 references indexed in Scilit:
- Design, synthesis of 1,2,4-triazine derivatives as antidepressant and antioxidant agents: In vitro, in vivo and in silico studiesBioorganic Chemistry, 2022
- Management of COVID-19-induced cytokine storm by Keap1-Nrf2 system: a reviewInflammopharmacology, 2021
- Unfolding Nrf2 in diabetes mellitusMolecular Biology Reports, 2021
- The acetyltransferase p300 regulates NRF2 stability and localizationBiochemical and Biophysical Research Communications, 2020
- Neurodegeneration by oxidative stress: a review on prospective use of small molecules for neuroprotectionMolecular Biology Reports, 2020
- Keap1, the cysteine-based mammalian intracellular sensor for electrophiles and oxidantsArchives of Biochemistry and Biophysics, 2017
- Nrf2 regulates ROS production by mitochondria and NADPH oxidaseBiochimica et Biophysica Acta (BBA) - General Subjects, 2015
- A phase II study of sulforaphane-rich broccoli sprout extracts in men with recurrent prostate cancerInvestigational New Drugs, 2014
- Binding Mode and Structure–Activity Relationships around Direct Inhibitors of the Nrf2–Keap1 ComplexChemMedChem, 2014
- CHARMM general force field: A force field for drug‐like molecules compatible with the CHARMM all‐atom additive biological force fieldsJournal of Computational Chemistry, 2009